Open Access

Polysaccharide peptide isolated from grass-cultured Ganoderma lucidum induces anti-proliferative and pro-apoptotic effects in the human U251 glioma cell line

  • Authors:
    • Chunhua Wang
    • Dongmei Lin
    • Quan Chen
    • Shuqian Lin
    • Songsheng Shi
    • Chunmei Chen
  • View Affiliations

  • Published online on: January 19, 2018     https://doi.org/10.3892/ol.2018.7823
  • Pages: 4330-4336
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: HTML 0 views | PDF 0 views     Cited By (CrossRef): 0 citations

Abstract

The Ganoderma lucidum (G. lucidum) mushroom is one of the most extensively studied functional foods, known for its numerous health benefits, including the inhibition of tumor cell growth. The present study assessed the anti-proliferative and pro‑apoptotic activity of a novel G. lucidum polysaccharide peptide (GL‑PP) in human glioma U251 cells, which was purified from grass‑cultured G. lucidum. GL‑PP is a glycopeptide with an average molecular weight of 42,635 Da and a polysaccharide‑to‑peptide ratio of 88.70:11.30. The polysaccharides were composed of l‑arabinose, d‑mannose and d‑glucose at a molar ratio of 1.329:0.372:2.953 and a total of 17 amino acids were detected. The results of the current study demonstrated that GL‑PP significantly inhibited U251 cellular proliferation. The proportion of G0/G1 phase cells and sub‑G1 phase cells significantly increased as the concentration of GL‑PP increased, as did the activity of caspase-3. These results indicate that GL‑PP directly inhibited human glioma U251 proliferation by inducing cell cycle arrest and promoting apoptosis.

References

1 

Omuro A and DeAngelis LM: Glioblastoma and other malignant gliomas: A clinical review. JAMA. 310:1842–1850. 2013. View Article : Google Scholar : PubMed/NCBI

2 

Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY and Olson JJ: Exciting new advances in neuro-oncology: The avenue to a cure for malignant glioma. CA Cancer J Clin. 60:166–193. 2010. View Article : Google Scholar : PubMed/NCBI

3 

Song YH, Sun H, Zhang AH, Yan GL, Han Y and Wang XJ: Plant-derived natural products as leads to anti-cancer drugs. J Med plant Herbal Ther Res. 2:6–15. 2014.

4 

Habijanic J, Berovic M, Boh B, Plankl M and Wraber B: Submerged cultivation of Ganoderma lucidum and the effects of its polysaccharides on the production of human cytokines TNF-α, IL-12, IFN-γ, IL-2, IL-4, IL-10 and IL-17. N Biotechnol. 32:85–95. 2015. View Article : Google Scholar : PubMed/NCBI

5 

Lai CY, Hung JT, Lin HH, Yu AL, Chen SH, Tsai YC, Shao LE, Yang WB and Yu J: Immunomodulatory and adjuvant activities of a polysaccharide extract of Ganoderma lucidum in vivo and in vitro. Vaccine. 28:4945–4954. 2010. View Article : Google Scholar : PubMed/NCBI

6 

Meng J, Hu X, Shan F, Hua H, Lu C, Wang E and Liang Z: Analysis of maturation of murine dendritic cells (DCs) induced by purified Ganoderma lucidum polysaccharides (GLPs). Int J Biol Macromol. 49:693–699. 2011. View Article : Google Scholar : PubMed/NCBI

7 

Shi Y, Cai D, Wang X and Liu X: Immunomodulatory effect of Ganoderma lucidum polysaccharides (GLP) on long-term heavy-load exercising mice. Int J Vitam Nutr Res. 82:383–390. 2012. View Article : Google Scholar : PubMed/NCBI

8 

Xu Z, Chen X, Zhong Z, Chen L and Wang Y: Ganoderma lucidum polysaccharides: Immunomodulation and potential anti-tumor activities. Am J Chin Med. 39:15–27. 2011. View Article : Google Scholar : PubMed/NCBI

9 

Yeh CH, Chen HC, Yang JJ, Chuang WI and Sheu F: Polysaccharides PS-G and protein LZ-8 from Reishi (Ganoderma lucidum) exhibit diverse functions in regulating murine macrophages and T lymphocytes. J Agric Food Chem. 58:8535–8544. 2010. View Article : Google Scholar : PubMed/NCBI

10 

Zhang S, Nie S, Huang D, Feng Y and Xie M: A novel polysaccharide from Ganoderma atrum exerts antitumor activity by activating mitochondria-mediated apoptotic pathway and boosting the immune system. J Agric Food Chem. 62:1581–1589. 2014. View Article : Google Scholar : PubMed/NCBI

11 

Gao Y, Gao H, Chan E, Tang W, Xu A, Yang H, Huang M, Lan J, Li X, Duan W, et al: Antitumor activity and underlying mechanisms of ganopoly, the refined polysaccharides extracted from Ganoderma lucidum, in mice. Immunol Invest. 34:171–198. 2005. View Article : Google Scholar : PubMed/NCBI

12 

Joseph S, Sabulal B, George V, Antony KR and Janardhanan KK: Antitumor and anti-inflammatory activities of polysaccharides isolated from Ganoderma lucidum. Acta Pharm. 61:335–342. 2011. View Article : Google Scholar : PubMed/NCBI

13 

Liang CJ, Lee CW, Sung HC, Chen YH, Chiang YC, Hsu HY, Tseng YC, Li CY, Wang SH and Chen YL: Ganoderma lucidum polysaccharides reduce lipopolysaccharide-induced interleukin-1 β expression in cultured smooth muscle cells and in thoracic aortas in mice. Evid Based Complement Alternat Med. 2014:3051492014. View Article : Google Scholar : PubMed/NCBI

14 

Shang D, Li Y, Wang C, Wang X, Yu Z and Fu X: A novel polysaccharide from Se-enriched Ganoderma lucidum induces apoptosis of human breast cancer cells. Oncol Rep. 25:267–272. 2011.PubMed/NCBI

15 

Shang D, Zhang J, Wen L, Li Y and Cui Q: Preparation, characterization, and antiproliferative activities of the Se-containing polysaccharide SeGLP-2B-1 from Se-enriched Ganoderma lucidum. J Agric Food Chem. 57:7737–7742. 2009. View Article : Google Scholar : PubMed/NCBI

16 

Wang J, Zhang L, Yu Y and Cheung PC: Enhancement of antitumor activities in sulfated and carboxymethylated polysaccharides of Ganoderma lucidum. J Agric Food Chem. 57:10565–10572. 2009. View Article : Google Scholar : PubMed/NCBI

17 

Cao QZ and Lin ZB: Antitumor and anti-angiogenic activity of Ganoderma lucidum polysaccharides peptide. Acta Pharmacol Sin. 25:833–838. 2004.PubMed/NCBI

18 

Cao QZ and Lin ZB: Ganoderma lucidum polysaccharides peptide inhibits the growth of vascular endothelial cell and the induction of VEGF in human lung cancer cell. Life Sci. 78:1457–1463. 2006. View Article : Google Scholar : PubMed/NCBI

19 

Kan Y, Chen T, Wu Y and Wu J and Wu J: Antioxidant activity of polysaccharide extracted from Ganoderma lucidum using response surface methodology. Int J Biol Macromol. 72:151–157. 2015. View Article : Google Scholar : PubMed/NCBI

20 

Liu W, Wang H, Pang X, Yao W and Gao X: Characterization and antioxidant activity of two low-molecular-weight polysaccharides purified from the fruiting bodies of Ganoderma lucidum. Int J Biol Macromol. 46:451–457. 2010. View Article : Google Scholar : PubMed/NCBI

21 

Yang Q, Wang S, Xie Y, Sun J and Wang J: HPLC analysis of Ganoderma lucidum polysaccharides and its effect on antioxidant enzymes activity and Bax, Bcl-2 expression. Int J Biol Macromol. 46:167–172. 2010. View Article : Google Scholar : PubMed/NCBI

22 

Zhao W, Jiang X, Deng W, Lai Y, Wu M and Zhang Z: Antioxidant activities of Ganoderma lucidum polysaccharides and their role on DNA damage in mice induced by cobalt-60 gamma-irradiation. Food Chem Toxicol. 50:303–309. 2012. View Article : Google Scholar : PubMed/NCBI

23 

Liang Z, Yi Y, Guo Y, Wang R, Hu Q and Xiong X: Chemical characterization and antitumor activities of polysaccharide extracted from Ganoderma lucidum. Int J Mol Sci. 15:9103–9116. 2014. View Article : Google Scholar : PubMed/NCBI

24 

Chang SS, Zhou D, Meng GL, Wu F, Wang S, Chen X and Xu JL: Effect of Ganoderma lucidum polysaccharides on oxidative stress of hyperlipidemic fatty liver in rats. Zhongguo Zhong Yao Za Zhi. 37:3102–3106. 2012.(In Chinese). PubMed/NCBI

25 

Zhang GL, Wang YH, Ni W, Teng HL and Lin ZB: Hepatoprotective role of Ganoderma lucidum polysaccharide against BCG-induced immune liver injury in mice. World J Gastroenterol. 8:728–733. 2002. View Article : Google Scholar : PubMed/NCBI

26 

Sun LX, Lin ZB, Duan XS, Lu J, Ge ZH, Li XJ, Li M, Xing EH, Jia J, Lan TF and Li WD: Ganoderma lucidum polysaccharides antagonize the suppression on lymphocytes induced by culture supernatants of B16F10 melanoma cells. J Pharm Pharmacol. 63:725–735. 2011. View Article : Google Scholar : PubMed/NCBI

27 

Sun LX, Lin ZB, Li XJ, Li M, Lu J, Duan XS, Ge ZH, Song YX, Xing EH and Li WD: Promoting effects of Ganoderma lucidum polysaccharides on B16F10 cells to activate lymphocytes. Basic Clin Pharmacol Toxicol. 108:149–154. 2011. View Article : Google Scholar : PubMed/NCBI

28 

Zhang P, Ding R, Jiang S, Ji L, Pan M, Liu L, Zhang W, Gao X, Huang W, Zhang G, et al: The adjuvanticity of Ganoderma lucidum polysaccharide for Newcastle disease vaccine. Int J Biol Macromol. 65:431–435. 2014. View Article : Google Scholar : PubMed/NCBI

29 

Zhu XL, Chen AF and Lin ZB: Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice. J Ethnopharmacol. 111:219–226. 2007. View Article : Google Scholar : PubMed/NCBI

30 

Zheng S, Jia Y, Zhao J, Wei Q and Liu Y: Ganoderma lucidum polysaccharides eradicates the blocking effect of fibrinogen on NK cytotoxicity against melanoma cells. Oncol Lett. 3:613–616. 2012. View Article : Google Scholar : PubMed/NCBI

31 

Cao QZ, Lin SQ and Wang SZ: Effect of Ganoderma lucidum polysaccharides peptide on invasion of human lung carcinoma cells in vitro. Beijing Da Xue Xue Bao Yi Xue Ban. 39:653–656. 2007.(In Chinese). PubMed/NCBI

32 

Oliveira M, Reis FS, Sousa D, Tavares C, Lima RT, Ferreira IC, dos Santos T and Vasconcelos MH: A methanolic extract of Ganoderma lucidum fruiting body inhibits the growth of a gastric cancer cell line and affects cellular autophagy and cell cycle. Food Funct. 5:1389–1394. 2014. View Article : Google Scholar : PubMed/NCBI

33 

Sun LX, Lin ZB, Duan XS, Lu J, Ge ZH, Li M, Xing EH, Lan TF, Jiang MM, Yang N and Li WD: Ganoderma lucidum polysaccharides counteract inhibition on CD71 and FasL expression by culture supernatant of B16F10 cells upon lymphocyte activation. Exp Ther Med. 5:1117–1122. 2013. View Article : Google Scholar : PubMed/NCBI

34 

Wang PY, Zhu XL and Lin ZB: Antitumor and immunomodulatory effects of polysaccharides from broken-spore of Ganoderma lucidum. Front Pharmacol. 3:1352012. View Article : Google Scholar : PubMed/NCBI

35 

Sun LX, Chen LH, Lin ZB, Qin Y, Zhang JQ, Yang J, Ma J, Ye T and Li WD: Effects of Ganoderma lucidum polysaccharides on IEC-6 cell proliferation, migration and morphology of differentiation benefiting intestinal epithelium healing in vitro. J Pharm Pharmacol. 63:1595–1603. 2011. View Article : Google Scholar : PubMed/NCBI

36 

Wang SZ, Lin ZX, Lin DM, Lin SQ, Lin ZB and Li J: Structure of polysaccharide peptide GL-PPS from Ganoderma lucidum. Southwest China J Agricultural Sci. 28:793–796. 2015.

37 

Gong Y, Huang Y, Gao L, Lu J, Hu Y, Xia L and Huang H: Chinese standard GB/T 5009. 124-2003. Inspection of grain and oilseeds: Method for determination of amino acids in foods. Standards press of China, Beijing, China, 2003. J Food Nut Res. 1:108–112. 2013.

38 

Boh B: Ganoderma lucidum: A potential for biotechnological production of anti-cancer and immunomodulatory drugs. Recent Pat Anticancer Drug Discov. 8:255–287. 2013. View Article : Google Scholar : PubMed/NCBI

39 

Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI

40 

Liu YJ, Shen J, Xia YM, Zhang J and Park HS: The polysaccharides from Ganoderma lucidum: Are they always inhibitors on human hepatocarcinoma cells? Carbohydr Polym. 90:1210–1215. 2012. View Article : Google Scholar : PubMed/NCBI

41 

Shen J, Park HS, Xia YM, Kim GS and Cui SW: The polysaccharides from fermented Ganoderma lucidum mycelia induced miRNAs regulation in suppressed HepG2 cells. Carbohydr Polym. 103:319–324. 2014. View Article : Google Scholar : PubMed/NCBI

42 

Li YB, Li YH, Wang R, Lin ZB and Li ZJ: Efect of Ganoderma lucidumpolysaccharides (GlPS) on tumor-endothelium interactions. Chin Pharmacol Bull. 39:250–253. 2008.

43 

Chen X, Xu X, Zhang L and Zeng F: Chain conformation and anti-tumor activities of phosphorylated (1→3)-β-d-glucan from Poria cocos. Carbohydr Polymers. 78:581–587. 2009. View Article : Google Scholar

44 

Surenjav U, Zhang L, Xu X, Zhang X and Zeng F: Effects of molecular structure on antitumor activities of (1→3)-β-d-glucans from different Lentinus Edodes. Carbohydr Polymers. 63:97–104. 2006. View Article : Google Scholar

45 

Wang Y, Zhang L, Li Y, Hou X and Zeng F: Correlation of structure to antitumor activities of five derivatives of a beta-glucan from Poria cocos sclerotium. Carbohydr Res. 339:2567–2574. 2004. View Article : Google Scholar : PubMed/NCBI

46 

Zhang L, Li X, Xu X and Zeng F: Correlation between antitumor activity, molecular weight, and conformation of lentinan. Carbohydr Res. 340:1515–1521. 2005. View Article : Google Scholar : PubMed/NCBI

47 

Wasser SP: Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol. 60:258–274. 2002. View Article : Google Scholar : PubMed/NCBI

48 

Lin SQ, Wang SZ, Lin ZB and Lin YX: Isolation and identification of active components of Ganoderma lucidum cultivated with grassand wood log I. Extraction, purification and characterization of glycopeptide. Chin Tradit Herbal Drugs. 34:872–874. 2003.

Related Articles

Journal Cover

April 2018
Volume 15 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Wang, C., Lin, D., Chen, Q., Lin, S., Shi, S., & Chen, C. (2018). Polysaccharide peptide isolated from grass-cultured Ganoderma lucidum induces anti-proliferative and pro-apoptotic effects in the human U251 glioma cell line. Oncology Letters, 15, 4330-4336. https://doi.org/10.3892/ol.2018.7823
MLA
Wang, C., Lin, D., Chen, Q., Lin, S., Shi, S., Chen, C."Polysaccharide peptide isolated from grass-cultured Ganoderma lucidum induces anti-proliferative and pro-apoptotic effects in the human U251 glioma cell line". Oncology Letters 15.4 (2018): 4330-4336.
Chicago
Wang, C., Lin, D., Chen, Q., Lin, S., Shi, S., Chen, C."Polysaccharide peptide isolated from grass-cultured Ganoderma lucidum induces anti-proliferative and pro-apoptotic effects in the human U251 glioma cell line". Oncology Letters 15, no. 4 (2018): 4330-4336. https://doi.org/10.3892/ol.2018.7823